Ocular rosacea: Signs, symptoms, and tear studies before and after treatment with doxycycline

Archives of Dermatology

Volumn 133, Issue 1, 1997, Pages 49-54

  Quarterman, Mark J ^a,b   Johnson, David W ^a,c   Abele, Donald C ^a   Lesher Jr , Jack L ^a   Hull, David S ^a   Davis, Loretta S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Private Practice   (United States)

^c Private Practice   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRY EYE; EYE DISEASE; FEMALE; HUMAN; MALE; PHOTOSENSITIVITY; PRIORITY JOURNAL; ROSACEA; SCHIRMER TEST; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 0031046260     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.1.49     Document Type: Article

References (24)

1. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69:419-423.
2. Plewig G, Kligman AM. Rosacea. In: Plewig G, Kligman AM, eds. Acne and Rosacea. New York, NY: Springer-Verlag; 1993:433-443.
3. Starr PAJ, Macdonald A. Oculocutaneous aspects of rosacea. Proc R Soc Med. 1969;62:9-11.
4. Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol. 1986;31:145-158.
5. Wise G. Ocular rosacea. Am J Ophthalmol. 1943;26:591-609.
6. Jenkins MS, Brown SI, Lempert SL, Weinberg RJ. Ocular rosacea. Am J Ophthalmol. 1979;88:618-622.
7. Gudmundsen KJ, O'Donnell BF, Powell FC. Schirmer testing for dry eyes in patients with rosacea. J Am Acad Dermatol. 1992;26:211-214.
8. Irvine C, Marks R. Prognosis and prognostic factors in rosacea. In: Marks R, Plewig G, eds. Acne and Related Disorders: Proceedings of an International Symposium, Cardiff, Wales, 1988. London, England: Martin Danitz; 1989:331- 333.
9. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788-793.
10. Lemp MA, Hamill JR. Factors affecting tear film breakup in normal eyes. Arch Ophthalmol. 1973;89:103-105.
11. Lamberts DW, Foster CS, Perry HD. Schirmer test after topical anesthesia and the tear meniscus height in normal eyes. Arch Ophthalmol. 1979;97:1082- 1085.
12. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 1953;65:458-463.
13. Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1994;130:359-362.
14. Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res. 1989;281:66-72.
15. Lemp MA. Diagnosis and treatment of tear deficiencies. In: Duane TD, Jaeger EA, eds. Clinical Ophthalmology. New York, NY: Harper & Row Publishers Inc; 1982;4:1-9.
16. Dohlman CH. Dry eyes: aspects of pathophysiology. Fortschr Ophthalmol. 1987;84:443-445.
17. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol. 1977;22:69-87.
18. Gibard JP. Dry eye disorders. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia, Pa: WB Saunders Co; 1994:257-276.
19. Carney LG, Hill RM. The nature of normal blinking. Acta Ophthalmol. 1982;60:427-433.
20. Abelson MB, Holly FJ. A tentative mechanism for inferior punctate keratopathy. Am J Ophthalmol. 1977;83:866-869.
21. Ramelet AA. Rosacea: a reaction pattern associated with ocular lesions and migraine? Arch Dermatol. 1994;130:1448.
22. Knight AG, Vickers CFH. A follow-up of tetracycline-treated rosacea: with special reference to rosacea keratitis. Br J Dermatol. 1975;93:577-580.
23. Brown SI, Shahinian L Jr. Diagnosis and treatment of ocular rosacea. Ophthalmology. 1978;85:779-786.
24. Lemp MA, Mahmood MA, Weiler HH. Association of rosacea and keratoconjunctivitis sicca. Arch Ophthalmol. 1984;102:556-557.